Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetic Neuropathy01:22

Diabetic Neuropathy

DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
Peripheral Artery Disease IV: Nursing Management01:26

Peripheral Artery Disease IV: Nursing Management

The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses, temperature changes,...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Modeling the Effects of Gravity and Patient Positioning on Stone Migration During Ureteroscopy with Laser Lithotripsy in a Physics-Based Simulator.

Urologia internationalis·2026
Same author

The influence of exercise modality on the inflammatory response to high-intensity interval training.

ImmunoHorizons·2026
Same author

Intrarenal Pressure During Steerable Ureteroscopy Renal Evacuation by CVAC System Using Intrarenal Pressure Measurement: A Pilot Study.

Journal of endourology·2026
Same author

Prevalence and Relative Proportions of MS, NMOSD, and MOGAD in the Republic of Korea.

Neurology·2026
Same author

Astrocyte Heterogeneity in Multiple Sclerosis From Reactive Glia to Therapeutic Targets.

Journal of clinical neurology (Seoul, Korea)·2026
Same author

Dual Component Framework Approach for Automated Nerve Conduction Study Interpretation: Rule-Based Coding and Fine-Tuned Language Model.

Muscle & nerve·2026
Same journal

Characterizing Combined Central and Peripheral Demyelination-Insights From a Multimodal Comparison With Chronic Inflammatory Demyelinating Polyneuropathy and Multiple Sclerosis.

Muscle & nerve·2026
Same journal

Electrical Modalities in the Rehabilitation of Peripheral Nerve Injuries: State of the Literature and Current Clinical Applications.

Muscle & nerve·2026
Same journal

Reply to "Sural/Radial Amplitude Ratio in Non-Length-Dependent Neuropathy (NLDN): A Call for More Standardized Methodology and Further Evaluation of Distal NLDN".

Muscle & nerve·2026
Same journal

Late-Onset Myasthenia Gravis: An Increasingly Frequent Clinical Entity With Distinctive Challenges.

Muscle & nerve·2026
Same journal

Clinical Characteristics and Treatment Management of Seronegative Myasthenia Gravis: A Systematic Review of the Literature.

Muscle & nerve·2026
Same journal

Muscle-Specific Kinase Signaling and Its Therapeutic Potential.

Muscle & nerve·2026
See all related articles

Related Experiment Video

Updated: Jun 19, 2026

Nerve Ultrasound Protocol to Detect Dysimmune Neuropathies
08:56

Nerve Ultrasound Protocol to Detect Dysimmune Neuropathies

Published on: October 7, 2021

Driving with polyneuropathy.

S Charles Cho1, Hans D Katzberg, Anil Rama

  • 1Stanford University School of Medicine, Room A343, 300 Pasteur Drive, Stanford, California 94305-5235, USA. chos@stanford.edu

Muscle & Nerve
|November 3, 2009
PubMed
Summary
This summary is machine-generated.

Patients with neuropathy experience higher motor vehicle accident rates. Neuropathy symptoms and medications contribute to accidents, but driving habits often adapt, requiring individualized assessment for driving safety.

More Related Videos

Effects of Mindfulness Training Combined with Tai Chi in Patients with Diabetic Peripheral Neuropathy
05:06

Effects of Mindfulness Training Combined with Tai Chi in Patients with Diabetic Peripheral Neuropathy

Published on: July 14, 2023

Related Experiment Videos

Last Updated: Jun 19, 2026

Nerve Ultrasound Protocol to Detect Dysimmune Neuropathies
08:56

Nerve Ultrasound Protocol to Detect Dysimmune Neuropathies

Published on: October 7, 2021

Effects of Mindfulness Training Combined with Tai Chi in Patients with Diabetic Peripheral Neuropathy
05:06

Effects of Mindfulness Training Combined with Tai Chi in Patients with Diabetic Peripheral Neuropathy

Published on: July 14, 2023

Area of Science:

  • Neurology
  • Traffic Safety
  • Public Health

Background:

  • Polyneuropathy can cause pain, numbness, and weakness, potentially impairing driving ability.
  • Neuropathic pain medications may affect cognition, further impacting driving safety.
  • Limited rigorous studies exist on motor vehicle accident (MVA) rates in neuropathy patients.

Purpose of the Study:

  • To investigate the MVA rate in patients with neuropathy.
  • To identify risk factors associated with accidents in this population.
  • To compare accident rates to national statistics.

Main Methods:

  • Surveyed 260 neuropathy patients from three medical centers regarding accident history.
  • Collected data on neuropathy symptoms, medication use, and changes in driving habits.
  • Compared patient MVA rates to National Highway Traffic Safety Administration (NHTSA) data.

Main Results:

  • 40.6% of surveyed patients reported traffic accidents, averaging 0.11 accidents/year.
  • The accident rate was 10.8 MVAs per million vehicle miles traveled (MVA/MVMT), significantly higher than national rates for comparable age groups.
  • Neuropathy (72.4%) and medications (55.2%) were cited as contributing factors; 51.6% modified driving habits.

Conclusions:

  • Neuropathy patients exhibit a higher frequency of motor vehicle accidents compared to age-matched national statistics.
  • Pain, motor weakness, and ambulation difficulty are independently associated with increased MVA frequency.
  • Driving safety concerns in neuropathy patients warrant a cautious, case-by-case evaluation, considering patient-reported habit modifications.